Skip to main content
Sirona Biochem Corp. logo

Sirona Biochem Corp. — Investor Relations & Filings

Ticker · SRBCF ISIN · CA82967M1005 LEI · 549300CQE1Q87IG6W210 TSXV Real estate activities
Open in API
Filings indexed 367 across all filing types
Latest filing 2020-03-03 Regulatory Filings
Country CA Canada
Listing TSXV SRBCF

About Sirona Biochem Corp.

https://www.sironabiochem.com/

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery firm utilizing a proprietary platform technology to develop novel compounds. Through its wholly-owned French subsidiary, TFChem, the company specializes in stabilizing carbohydrate molecules, often via fluorination chemistry, to enhance their efficacy and safety for medical and cosmetic applications. Sirona Biochem's business strategy involves licensing or selling its patented compounds, such as the anti-aging and anti-wrinkle molecule GlycoProteMim™ (TFC-1326), to leading global pharmaceutical and cosmetic companies in exchange for up-front fees, milestone payments, and ongoing royalties.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2020-03-03 English
Annual MD&A - English.pdf
Regulatory Filings
2020-03-03 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-03-03 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 90% confidence The document is a notice from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General Meeting (AGM) of Sirona BioChem Corp. It provides details about the meeting date, record dates, and voting security details. The document is short (1029 characters) and serves as an announcement about the AGM rather than the AGM materials or presentations themselves. Therefore, it fits best as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2020-02-24 English
Letter from successor auditor.pdf
Audit Report / Information Classification · 95% confidence The document is a letter addressed to multiple Canadian securities commissions and the TSX Venture Exchange, referencing National Instrument 51-102, which governs continuous disclosure obligations including auditor changes. The letter announces the resignation of the previous auditor and appointment of a new auditor, and includes a confirmation from the new auditor regarding the change. The document is short (1602 characters) and is a formal notification of auditor change rather than a full audit report or annual report. It does not contain financial statements or detailed audit results. Therefore, it fits the category of Audit Report / Information (AR), specifically a notice related to auditor change under audit-related disclosures. FY 2020
2020-02-13 English
Letter from former auditor.pdf
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to securities commissions regarding a change of auditor, referencing National Instrument 51-102. It is a certification or attestation by the outgoing auditor agreeing with the company's notice of auditor change. The document does not contain financial statements or detailed audit information, nor is it a full audit report. It is primarily a regulatory filing related to auditor change compliance. Given the short length and nature, it fits best under Regulatory Filings (RNS) as it is a compliance notice rather than a full audit report or annual report.
2020-02-13 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.